ProfessorPeter Grimison

"Peter Grimison is Senior Staff Specialist in Medical Oncology at the Chris O'Brien Lifehouse in Sydney; Visiting Medical Officer at Royal Prince Alfred Hospital; and Clinical Professor at the University of Sydney.

His clinical work focuses on sarcoma (as the adult medical oncology lead at Chris O'Brien Lifehouse and Royal Prince Alfred Hospital), testicular cancer, and neuroendocrine tumours. He has been a member of the Australian Government's Pharmaceutical Benefits Advisory Committee since 2015, and contributes to several other Federal and NSW Government committees. He chairs two independent data safety monitoring committees, and serves on the editorial boards of the Annals of Oncology and the Journal of the National Cancer Institute. He is also committed to teaching as Director of Physician Training in Medical Oncology at the Chris O'Brien Lifehouse and supervisor of PhD and MD students, and also actively teaches in Basic Physician Training and the University of Sydney Medical Program.

Professor Grimison's research interests incorporate clinical and translational research about sarcoma and testicular cancer, oncology supportive care and health services research, and quality of life assessment in clinical trials (PhD completed). He is involved as member of the scientific advisory committee, international study char, ANZ lead, and site principal investigator in several national and international trials for the Australia New Zealand Sarcoma Association (ANZSA), and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) whose coordinating centre is based at the NHMRC Clinical Trials Centre of the University of Sydney, He was study chair for the world's largest trial of medicinal cannabis for the control of chemotherapy-induced nausea and vomiting. He is the medical oncology lead for the Sarcoma of the Pelvic and Abdominal Retroperitoneum Collaboration (SPARC). He is also actively involved in phase I, II, and III clinical trials for industry sponsors."